annual CFF:
$12.19M+$410.07M(+103.06%)Summary
- As of today (May 24, 2025), SUPN annual cash flow from financing activities is $12.19 million, with the most recent change of +$410.07 million (+103.06%) on December 31, 2024.
- During the last 3 years, SUPN annual CFF has risen by +$142.61 million (+109.35%).
- SUPN annual CFF is now -96.76% below its all-time high of $376.44 million, reached on December 31, 2018.
Performance
SUPN Cash from financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CFF:
-$21.40M-$27.29M(-463.31%)Summary
- As of today (May 24, 2025), SUPN quarterly cash flow from financing activities is -$21.40 million, with the most recent change of -$27.29 million (-463.31%) on March 31, 2025.
- Over the past year, SUPN quarterly CFF has dropped by -$22.97 million (-1462.99%).
- SUPN quarterly CFF is now -105.82% below its all-time high of $367.71 million, reached on March 31, 2018.
Performance
SUPN quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFF:
-$10.78M-$22.97M(-188.38%)Summary
- As of today (May 24, 2025), SUPN TTM cash flow from financing activities is -$10.78 million, with the most recent change of -$22.97 million (-188.38%) on March 31, 2025.
- Over the past year, SUPN TTM CFF has increased by +$465.71 million (+97.74%).
- SUPN TTM CFF is now -102.85% below its all-time high of $377.88 million, reached on June 30, 2018.
Performance
SUPN TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash from financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
SUPN Cash from financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +103.1% | -1463.0% | +97.7% |
| 3 y3 years | +109.3% | +2.9% | +93.0% |
| 5 y5 years | +210.4% | -10000.0% | -439.2% |
SUPN Cash from financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +103.1% | -126.7% | +95.5% | -111.8% | +97.7% |
| 5 y | 5-year | at high | +103.1% | -126.7% | +95.5% | -111.8% | +97.7% |
| alltime | all time | -96.8% | +103.1% | -105.8% | +95.5% | -102.8% | +97.7% |
SUPN Cash from financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | -$21.40M(-463.3%) | -$10.78M(-188.4%) |
| Dec 2024 | $12.19M(-103.1%) | $5.89M(+91.5%) | $12.19M(+64.9%) |
| Sep 2024 | - | $3.08M(+85.5%) | $7.39M(+80.8%) |
| Jun 2024 | - | $1.66M(+5.6%) | $4.09M(-100.9%) |
| Mar 2024 | - | $1.57M(+43.8%) | -$476.48M(+19.8%) |
| Dec 2023 | -$397.88M(+3697.7%) | $1.09M(-574.8%) | -$397.88M(+0.4%) |
| Sep 2023 | - | -$230.00K(-100.0%) | -$396.14M(+1.7%) |
| Jun 2023 | - | -$478.92M(-697.3%) | -$389.46M(-524.6%) |
| Mar 2023 | - | $80.17M(+2734.0%) | $91.73M(-975.5%) |
| Dec 2022 | -$10.48M(-92.0%) | $2.83M(-56.2%) | -$10.48M(-93.0%) |
| Sep 2022 | - | $6.46M(+184.0%) | -$150.05M(-3.3%) |
| Jun 2022 | - | $2.27M(-110.3%) | -$155.18M(+0.3%) |
| Mar 2022 | - | -$22.03M(-83.9%) | -$154.70M(+18.6%) |
| Dec 2021 | -$130.42M(-3764.5%) | -$136.74M(<-9900.0%) | -$130.42M(-1489.1%) |
| Sep 2021 | - | $1.32M(-51.8%) | $9.39M(+32.5%) |
| Jun 2021 | - | $2.75M(+22.3%) | $7.09M(+22.7%) |
| Mar 2021 | - | $2.25M(-26.8%) | $5.77M(+62.2%) |
| Dec 2020 | $3.56M(-9.4%) | $3.07M(-413.5%) | $3.56M(+103.0%) |
| Sep 2020 | - | -$979.00K(-168.1%) | $1.75M(-41.1%) |
| Jun 2020 | - | $1.44M(+4390.6%) | $2.97M(-6.4%) |
| Mar 2020 | - | $32.00K(-97.5%) | $3.18M(-19.1%) |
| Dec 2019 | $3.93M(-99.0%) | $1.26M(+421.9%) | $3.93M(+0.3%) |
| Sep 2019 | - | $242.00K(-85.2%) | $3.92M(-13.0%) |
| Jun 2019 | - | $1.64M(+109.5%) | $4.50M(-52.7%) |
| Mar 2019 | - | $783.00K(-37.4%) | $9.51M(-97.5%) |
| Dec 2018 | $376.44M(+6526.3%) | $1.25M(+51.1%) | $376.44M(+0.0%) |
| Sep 2018 | - | $828.00K(-87.5%) | $376.36M(-0.4%) |
| Jun 2018 | - | $6.65M(-98.2%) | $377.88M(+1.4%) |
| Mar 2018 | - | $367.71M(>+9900.0%) | $372.79M(+6462.0%) |
| Dec 2017 | $5.68M | $1.17M(-50.1%) | $5.68M(+7.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2017 | - | $2.35M(+50.4%) | $5.31M(+64.8%) |
| Jun 2017 | - | $1.56M(+158.3%) | $3.22M(+27.2%) |
| Mar 2017 | - | $604.00K(-24.2%) | $2.53M(+23.4%) |
| Dec 2016 | $2.05M(+9.9%) | $797.00K(+206.5%) | $2.05M(-0.1%) |
| Sep 2016 | - | $260.00K(-70.1%) | $2.06M(+10.9%) |
| Jun 2016 | - | $871.00K(+602.4%) | $1.85M(+0.5%) |
| Mar 2016 | - | $124.00K(-84.5%) | $1.84M(-1.2%) |
| Dec 2015 | $1.87M(-93.9%) | $800.00K(+1279.3%) | $1.87M(+36.0%) |
| Sep 2015 | - | $58.00K(-93.3%) | $1.37M(-95.6%) |
| Jun 2015 | - | $862.00K(+486.4%) | $31.33M(+2.0%) |
| Mar 2015 | - | $147.00K(-52.0%) | $30.71M(+0.5%) |
| Dec 2014 | $30.57M(-51.3%) | $306.00K(-99.0%) | $30.57M(+6.1%) |
| Sep 2014 | - | $30.01M(>+9900.0%) | $28.81M(-2457.6%) |
| Jun 2014 | - | $245.00K(+4800.0%) | -$1.22M(-101.9%) |
| Mar 2014 | - | $5000.00(-100.3%) | $63.77M(+1.6%) |
| Dec 2013 | $62.74M(-28.6%) | -$1.45M(+7977.8%) | $62.74M(-41.1%) |
| Sep 2013 | - | -$18.00K(-100.0%) | $106.57M(+2.1%) |
| Jun 2013 | - | $65.23M(-6489.0%) | $104.36M(+18.7%) |
| Mar 2013 | - | -$1.02M(-102.4%) | $87.95M(+0.0%) |
| Dec 2012 | $87.92M(+224.6%) | $42.38M(-2004.5%) | $87.92M(+45.5%) |
| Sep 2012 | - | -$2.23M(-104.6%) | $60.43M(-1.5%) |
| Jun 2012 | - | $48.82M(-4718.9%) | $61.34M(+356.9%) |
| Mar 2012 | - | -$1.06M(-107.1%) | $13.43M(-50.4%) |
| Dec 2011 | $27.09M(-2969.4%) | $14.89M(-1230.4%) | $27.09M(+122.0%) |
| Sep 2011 | - | -$1.32M(-244.4%) | $12.20M(-9.7%) |
| Jun 2011 | - | $912.00K(-92.8%) | $13.52M(+7.2%) |
| Mar 2011 | - | $12.61M | $12.61M |
| Dec 2010 | -$944.00K(-122.1%) | - | - |
| Dec 2009 | $4.28M(-93.4%) | - | - |
| Dec 2008 | $64.46M(>+9900.0%) | - | - |
| Dec 2007 | $5000.00 | - | - |
FAQ
- What is Supernus Pharmaceuticals annual cash flow from financing activities?
- What is the all time high annual CFF for Supernus Pharmaceuticals?
- What is Supernus Pharmaceuticals annual CFF year-on-year change?
- What is Supernus Pharmaceuticals quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Supernus Pharmaceuticals?
- What is Supernus Pharmaceuticals quarterly CFF year-on-year change?
- What is Supernus Pharmaceuticals TTM cash flow from financing activities?
- What is the all time high TTM CFF for Supernus Pharmaceuticals?
- What is Supernus Pharmaceuticals TTM CFF year-on-year change?
What is Supernus Pharmaceuticals annual cash flow from financing activities?
The current annual CFF of SUPN is $12.19M
What is the all time high annual CFF for Supernus Pharmaceuticals?
Supernus Pharmaceuticals all-time high annual cash flow from financing activities is $376.44M
What is Supernus Pharmaceuticals annual CFF year-on-year change?
Over the past year, SUPN annual cash flow from financing activities has changed by +$410.07M (+103.06%)
What is Supernus Pharmaceuticals quarterly cash flow from financing activities?
The current quarterly CFF of SUPN is -$21.40M
What is the all time high quarterly CFF for Supernus Pharmaceuticals?
Supernus Pharmaceuticals all-time high quarterly cash flow from financing activities is $367.71M
What is Supernus Pharmaceuticals quarterly CFF year-on-year change?
Over the past year, SUPN quarterly cash flow from financing activities has changed by -$22.97M (-1462.99%)
What is Supernus Pharmaceuticals TTM cash flow from financing activities?
The current TTM CFF of SUPN is -$10.78M
What is the all time high TTM CFF for Supernus Pharmaceuticals?
Supernus Pharmaceuticals all-time high TTM cash flow from financing activities is $377.88M
What is Supernus Pharmaceuticals TTM CFF year-on-year change?
Over the past year, SUPN TTM cash flow from financing activities has changed by +$465.71M (+97.74%)